Vimarsana
Biggest News Aggregation in the World

Page 11 - Mid Year News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mid Year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mid Year Today - Breaking & Trending Today

Ports of Auckland CEO Tony Gibson says mid-year results grim but productivity on rise - Vimarsana News

Ports of Auckland CEO Tony Gibson says mid-year results grim but productivity on rise

Port says full steam ahead from July as automation project goes live.

Port of Tauranga mid-year profit up despite rough waters - Vimarsana News

Port of Tauranga mid-year profit up despite rough waters

Port of Tauranga mid-year profit up despite rough waters 25 Feb, 2021 07:32 PM 6 minutes to read Port of Tauranga confident of its own abilities amid supply chain congestion. Photo / Supplied Port of Tauranga turned in a mid-year 2.3 per cent increase in group net profit after tax, despite volatile cargo volumes and fallout from supply chain congestion and severe ship delays at Auckland. Group net profit after tax for the first six months of the 2021 financial year to December was $49.4 million, achieved despite a 1.3 per cent decrease in total trade volumes to 13.1m tonnes. Revenue was $159....

Cybrexa Therapeutics Reports Positive Results from GLP Toxicology Study of Lead Candidate CBX-12 (alphalex-exatecan) - Vimarsana News

Cybrexa Therapeutics Reports Positive Results from GLP Toxicology Study of Lead Candidate CBX-12 (alphalex-exatecan)

Cybrexa Therapeutics Reports Positive Results from GLP Toxicology Study of Lead Candidate CBX-12 (alphalex-exatecan) - No Unexpected Safety Findings During the Course of the Study - - On Track to File an IND in the First Quarter 2021 and Commence Phase I Trial by Mid Year 2021 - NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex Peptide Drug Conjugate (PDC) tumor targeting platform, today announced that it has completed the GLP toxicology study of its lead candidate, ...

MSNBC MSNBC Live With Craig Melvin December 11, 2019 16:46:00 - Vimarsana News

MSNBC MSNBC Live With Craig Melvin December 11, 2019 16:46:00

That that we issued last year on the midyear investigation and among other things, criticized what occurred last year with regard to the handling of that investigation. on going investigations are -- need to be protected from outside influence. you don't know as an investigator or you shouldn't conclude as an investigator until you are done with the investigation, you shouldn't be reaching your conclusions until that point. so giving preliminary ideas, advice, guidance, statements, can be misleading and you should not be leaching final conclusions until you get to the end of the investigation....

MSNBC MSNBC Live With Craig Melvin December 11, 2019 16:04:00 - Vimarsana News

MSNBC MSNBC Live With Craig Melvin December 11, 2019 16:04:00

Decision to task a confidential human source to con sensely monitor, in other words record, conversations with members of a political campaign. just in terms of that, it's worth noting that had in the midyear investigation which was the clinton email investigation or in this investigation, the fbi could have at the supervisory advisory level authorize an undercover -- authorized a confidential human source to have a con sensely monitored conversation with either of the presidential candidates with no notice to the department of justice or any lawyer in the department of justice. in crossfire h...